Replies

"Therapeutics are also now available to disrupt the course of the illness."

You see this written all over the place, but you never see a definition of the "new therapeutics."

The author mentions Paxlovid.
The CDC in COVID-19 Treatments and Therapeutics mentions "Pfizer's Paxlovid and Merck's molnupiravir, for the treatment of COVID-19 in certain patients."
The CDC links to the FDA for monoclonal antibodies: "COVID-19 monoclonal antibody therapeutics (mAb) are available for people ages 12 years or older."
For hospitalized patients, CDC recommends: "Remdesivir is an antiviral drug approved by the FDA for the treatment of COVID-19 in hospitalized adults and hospitalized pediatric patients at least 12 years of age."

The bottom lines are 1) there really are no other new "therapeutic" treatments the past 24 months except for the oral anti-virals Paxlovid (Pfizer) and Lagevrio (molnupiravir) (Merck), 2) a couple of new MABs, and 3) the government STILL continues to ignore Ivermectin, vitamins, and mineral supplements.